As a nurse practitioner admitting and following up psychiatric patients, what medical evaluations, labs, and monitoring are required?

Medical Evaluation and Monitoring for Psychiatric Admissions

As an NP in a psychiatric hospital, you need a targeted medical workup focused on vital signs, basic metabolic panel (BMP), complete blood count (CBC), creatine kinase (CK), urine drug screen (UDS), and serum ethanol level—with additional testing only when clinically indicated by history, physical exam findings, or abnormal vitals.

Initial Medical Screening

Essential Labs for All Admissions

The evidence strongly supports selective rather than comprehensive screening 1, 2. Your baseline workup should include:

• Vital signs (including orthostatic blood pressure)
• Comprehensive metabolic panel (CMP) or at minimum BMP with creatinine
• Complete blood count (CBC)
• Creatine kinase (CK) - particularly important as elevated CK was the most common cause requiring medical intervention (50.8% of IV fluid administrations and 53.3% of medical admissions) 1
• Urine drug screen (UDS) and serum ethanol level 1, 3
• Urinalysis - though lower yield than other tests 1
• Urine pregnancy test for all females of childbearing age

High-Risk Populations Requiring Expanded Workup

Order additional testing when patients present with 1, 2:

• Agitation or combativeness → Add CK, ensure CMP
• Abnormal vital signs (tachycardia, hypertension, fever) → Add CK, consider cardiac workup
• Intoxication or stimulant use history → CK is critical; consider troponin if chest pain or cardiac symptoms
• Age >65 years → More comprehensive screening warranted
• Evidence of self-neglect or disorientation → Full metabolic workup, consider B12/folate
• Low socioeconomic status or state hospital transfers → More thorough screening

Medication-Specific Monitoring

Antipsychotic Monitoring (General)

When patients are on or starting antipsychotics 4:

• Baseline ECG - screen for QTc prolongation risk
• Monitor for QTc-prolonging drug interactions (macrolides, fluoroquinolones, ondansetron, antihistamines)
• Cardiorespiratory monitoring after chemical restraint
• Document baseline abnormal movements before starting medications to distinguish from medication-induced effects 5

Clozapine-Specific Protocol

If patients are on clozapine, follow this rigorous schedule 6:

ANC Monitoring:

• Weekly ANC for first 18 weeks
• Every 4 weeks from week 18 until 2 years
• Annual CBC after 2 years (for hematologic malignancy screening, not neutropenia)
• Threshold for concern: ANC <1.0×10⁹ cells/L (or <0.5 for benign ethnic neutropenia)

Adverse Drug Reaction Monitoring (every 3 months after 2 years):

• Metabolic syndrome parameters (weight, glucose, lipids)
• Constipation and GI hypomotility
• Gastroesophageal reflux
• Sialorrhea and choking risk
• Sedation level
• Nocturnal enuresis
• Orthostatic hypotension and dizziness
• Tachycardia
• Sleep apnea symptoms
• Seizures or myoclonus
• OCD symptoms
• Pneumonia risk
• Sexual dysfunction
• Heart failure signs

Clozapine Levels: Monitor annually and with: smoking pattern changes, infections/inflammatory illness, mental state changes, new ADRs, or CYP1A2 inhibitor addition/cessation 6

Cardiac Monitoring:

• ECG annually
• Echocardiogram only if clinically indicated 6

Follow-Up Monitoring Schedule

Acute Phase

• At least monthly physician contact to monitor symptoms, side effects, and medication adherence 5
• More frequent visits (weekly initially) after stabilization to establish rapport and ensure compliance

Maintenance Phase

• Every 3 months for stable patients on clozapine (if seeing psychiatrist only) 6
• Every 6-12 months psychiatric prescriber visit if shared care with primary care
• Every 3 months primary care visit for ADR screening in shared care model

Common Pitfalls to Avoid

1. Don't order extensive screening batteries reflexively - Most abnormalities found on comprehensive screening are clinically insignificant and don't affect management 2

2. Don't miss elevated CK - This is the single most important predictor of need for medical intervention before psychiatric admission 1

3. Don't forget to check for drug interactions - Particularly QTc-prolonging medications when using antipsychotics 4

4. Don't skip vital signs - Abnormal vitals are a key trigger for expanded workup 1

5. Don't assume young patients need less screening - While older patients warrant more comprehensive evaluation, younger patients with agitation, substance use, or abnormal vitals need thorough CK and metabolic assessment 1

When to Obtain Medical Admission vs Psychiatric Admission

Transfer to medical service when 1:

• Significantly elevated CK (most common cause of medical admission)
• Acute kidney injury
• Seizures with leukocytosis
• Suspected acute coronary syndrome
• Severe alcohol withdrawal requiring intensive monitoring
• Encephalopathy with hematologic abnormalities

The key is using history, physical exam, and vital signs to guide selective testing rather than ordering comprehensive panels on everyone. This approach identifies the patients who need medical intervention while avoiding unnecessary testing and costs.